Maynard Ryan D

Average Profitability
15.11%
Insider Buys Quantity
1
Insider Buys Sum
$50,587.50
Insider Sells Quantity
7
Insider Sells Sum
$1.96M

Insider Activity of Maynard Ryan D

According to the SEC Form 4 filings, Maynard Ryan D, being in a position of

  1. director at Iovance Biotherapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 50000 shares for $503,000,
    over all time since 2022-05-31, has bought 7500 shares for $50,588, and sold 50000 shares for $503,000.

The largest purchase of all time was on 2022-05-31 and amounted to 7500 shares of Iovance Biotherapeutics, Inc. for $50,588.

The largest sale of all time was on 2012-09-07 and amounted to 57414 shares of Rigel Pharmaceuticals, Inc. for $608,520.

Biography of Maynard Ryan D

No biography is available at this moment.

2024-11-12SaleIovance Biotherapeutics, Inc.
IOVA
director
50,000
0.0169%
$10.06$503,000-14.96%
2023-02-08SaleCara Therapeutics, Inc.
CARA
CHIEF FINANCIAL OFFICER
5,488
0.0005%
$0.53$2,909-75.54%
2022-05-31PurchaseIovance Biotherapeutics, Inc.
IOVA
7,500
0.0048%
$6.75$50,588+15.11%
2017-11-03SaleRigel Pharmaceuticals, Inc.
RIGL
EVP & CFO
100,000
0.0697%
$3.90$390,000-7.47%
2012-09-12SaleRigel Pharmaceuticals, Inc.
RIGL
EVP & CFO
23,302
0.0328%
$10.67$248,560-38.28%
2012-09-10SaleRigel Pharmaceuticals, Inc.
RIGL
EVP & CFO
17,586
0.0253%
$10.52$184,927-35.8%
2012-09-07SaleRigel Pharmaceuticals, Inc.
RIGL
EVP & CFO
57,414
0.081%
$10.60$608,520-37.46%
2012-08-07SaleRigel Pharmaceuticals, Inc.
RIGL
EVP & CFO
1,700
0.0024%
$10.61$18,041-34.63%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.